Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Tetanus × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Osteosarcoma 2 Lymphoma 2 Leukemia 2 Glioblastoma 2 Xanthomatosis, Cerebrotendinous 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Tetanus 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Kidney Neoplasms 1 Influenza, Human 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1 Colonic Neoplasms 1

Interventions

sargramostim 1 Temozolomide 1 Granulocyte-Macrophage Colony-Stimulating Factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03927222 2024-04-08

I-ATTAC

Duke University

Phase 2 Terminated

6 enrolled 7 charts

Glioblastoma, Tetanus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡